Immatics To Go Public Through Merger With ‘Blank Check’ Company Arya

 
• By Joseph Haas
T Cell lymphocyte with receptors for cancer cell immunotherapy research 3D render
Immatics now will have a public listing and plenty of cash to advance its TCR pipeline

More from Deals

More from Business